Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. A well-crafted resume could boost your confidence while you job ...
Discover the real January 6 story: peaceful protest turned tragedy, Deep State entrapment, media deception, and President ...
MIDLAND, Pa., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”) announced today that it has filed an adversary proceeding in the United ...
STOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its inaugural syndicated credit facility. The new aggregate $980 ...
{{ .fieldName }} // Get field from current item +{{ ["field with spaces"] }} // Field names with spaces/special chars +Stop searching through documentation! This ...
MIDLAND, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a U.S. based technology company that designs, builds, and operates ...
VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) -- VR Resources Limited (“VR” or the “Company”, TSXV: VRR) has extended to January 18 th, 2026, the outside date of its proposed offering of ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ ...
Mawson Infrastructure Group Inc. - GlobeNewswire - Tue Nov 25, 5:00AM CST MIDLAND, Pa., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a ...
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that MYQORZO® (aficamten) has been approved by the China National Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback